X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Strides Arcolab with Aventis Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES SHASUN LTD vs SANOFI INDIA - Comparison Results

STRIDES SHASUN LTD    Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

SANOFI INDIA 
   Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STRIDES SHASUN LTD SANOFI INDIA STRIDES SHASUN LTD/
SANOFI INDIA
 
P/E (TTM) x 15.2 32.9 46.3% View Chart
P/BV x 1.8 6.3 28.2% View Chart
Dividend Yield % 0.6 1.4 39.0%  

Financials

 STRIDES SHASUN LTD   SANOFI INDIA
EQUITY SHARE DATA
    STRIDES SHASUN LTD
Mar-17
SANOFI INDIA
Dec-16
STRIDES SHASUN LTD/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs1,2754,560 28.0%   
Low Rs9184,400 20.9%   
Sales per share (Unadj.) Rs389.61,028.5 37.9%  
Earnings per share (Unadj.) Rs28.0129.0 21.7%  
Cash flow per share (Unadj.) Rs48.9186.0 26.3%  
Dividends per share (Unadj.) Rs4.5068.00 6.6%  
Dividend yield (eoy) %0.41.5 27.0%  
Book value per share (Unadj.) Rs303.1753.6 40.2%  
Shares outstanding (eoy) m89.4223.03 388.3%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.84.4 64.6%   
Avg P/E ratio x39.234.7 112.8%  
P/CF ratio (eoy) x22.424.1 93.1%  
Price / Book Value ratio x3.65.9 60.8%  
Dividend payout %16.152.7 30.5%   
Avg Mkt Cap Rs m98,036103,174 95.0%   
No. of employees `0005.83.6 160.1%   
Total wages/salary Rs m5,8813,592 163.7%   
Avg. sales/employee Rs Th6,005.96,537.7 91.9%   
Avg. wages/employee Rs Th1,014.0991.4 102.3%   
Avg. net profit/employee Rs Th431.2819.8 52.6%   
INCOME DATA
Net Sales Rs m34,83423,686 147.1%  
Other income Rs m1,686708 238.1%   
Total revenues Rs m36,52024,394 149.7%   
Gross profit Rs m6,4285,281 121.7%  
Depreciation Rs m1,8721,313 142.5%   
Interest Rs m2,26915 15,128.7%   
Profit before tax Rs m3,9734,661 85.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m40-   
Extraordinary Inc (Exp) Rs m-1,0060-   
Tax Rs m4701,691 27.8%   
Profit after tax Rs m2,5012,970 84.2%  
Gross profit margin %18.522.3 82.8%  
Effective tax rate %11.836.3 32.6%   
Net profit margin %7.212.5 57.3%  
BALANCE SHEET DATA
Current assets Rs m38,16515,673 243.5%   
Current liabilities Rs m30,4026,678 455.3%   
Net working cap to sales %22.338.0 58.7%  
Current ratio x1.32.3 53.5%  
Inventory Days Days7776 101.8%  
Debtors Days Days10422 468.2%  
Net fixed assets Rs m37,6398,098 464.8%   
Share capital Rs m894230 388.3%   
"Free" reserves Rs m26,21017,088 153.4%   
Net worth Rs m27,10517,356 156.2%   
Long term debt Rs m16,3770-   
Total assets Rs m81,16825,400 319.6%  
Interest coverage x2.8311.7 0.9%   
Debt to equity ratio x0.60-  
Sales to assets ratio x0.40.9 46.0%   
Return on assets %5.911.8 50.0%  
Return on equity %9.217.1 53.9%  
Return on capital %12.126.9 44.7%  
Exports to sales %024.5 0.0%   
Imports to sales %028.0 0.0%   
Exports (fob) Rs mNA5,801 0.0%   
Imports (cif) Rs mNA6,627 0.0%   
Fx inflow Rs m13,4657,145 188.5%   
Fx outflow Rs m4,0766,846 59.5%   
Net fx Rs m9,389299 3,140.3%   
CASH FLOW
From Operations Rs m2,8813,226 89.3%  
From Investments Rs m-7,051-1,555 453.5%  
From Financial Activity Rs m3,382-1,818 -186.0%  
Net Cashflow Rs m-788-147 535.8%  

Share Holding

Indian Promoters % 27.7 0.0 -  
Foreign collaborators % 0.0 60.4 -  
Indian inst/Mut Fund % 37.8 14.4 262.5%  
FIIs % 8.6 14.6 58.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.9 10.5 246.7%  
Shareholders   56,241 15,184 370.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STRIDES SHASUN LTD With:   WYETH LTD  PIRAMAL ENTERPRISES  ALKEM LABORATORIES  SUN PHARMA  PFIZER  

Compare STRIDES SHASUN LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty Close at Record Highs; Bank & Realty Stocks Rally(Closing)

After opening the day marginally higher, Indian share markets extended gains in the afternoon session after the government decided to cut tax rates on certain products and services.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

The ONLY Thing You Need to Know About Bitcoin(The 5 Minute Wrapup)

Jan 6, 2018

You either want it or you want to get as far away from it as possible - but Bitcoin is just the noise masking the REAL opportunity. Read about it here...

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STRIDES SHASUN LTD SHARE PRICE


Jan 19, 2018 (Close)

TRACK STRIDES SHASUN LTD

  • Track your investment in STRIDES SHASUN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES SHASUN LTD

STRIDES SHASUN LTD - AJANTA PHARMA COMPARISON

COMPARE STRIDES SHASUN LTD WITH

MARKET STATS